Live Breaking News & Updates on பெங்களூர் அடிப்படையிலானது பயோகான்

Results: Biocon’s revenue up at Rs 2,044 crore in Q4 of FY21
Results: Biocon’s revenue up at Rs 2,044 crore in Q4 of FY21
Bangalore-based Biocon reported a 26 per cent rise in consolidated revenue from Rs 1,621 crore in Q4FY20 to Rs 2,044 crore in Q4FY 2021. Indian biopharmaceutical company registered a net profit of over 100 per cent, at Rs 254 crore in Q4FY20.
The consolidated revenue grew 14 per cent to Rs 7,360 crore in FY21 from Rs 6,462 crore in FY20. In FY21, the net profit (before exceptional item and discontinuing operations) was at Rs 754 crore was down 4 per cent. The net profit was marginally down by 1 per cent at Rs 740 crore in FY 2021, from Rs 748 crore. While gross research and development was down by 2 per cent quarter on quarter; year on year basis it was up by 19 per cent, at Rs 627 crore. ....

Kiran Mazumdar Shaw , Research Services , Biocon Group , Bangalore Based Biocon , Executive Chairperson , Electronic City , கிறன் மஜும்தர் ஷா , ஆராய்ச்சி சேவைகள் , பயோகான் குழு , பெங்களூர் அடிப்படையிலானது பயோகான் , நிர்வாகி தலைவர் , மின்னணு நகரம் ,